November 18, 2024
(press release)
–
1 min read Insights Kimberly-Clark Corporation has announced that Joseph Romanelli, president of Human Health International for Merck & Co, (MSD) has been elected to its board of directors, effective immediately. In connection with the election, Kimberly-Clark's board size will increase from 12 to 13 directors. "Joe Romanelli is an outstanding addition to the Kimberly-Clark board of directors," said Mike Hsu, chairman and chief executive officer of Kimberly-Clark. "As we advance our powering care strategy, we will benefit from Romanelli’s global leadership experience and his expertise in using leading-edge science to save and improve lives around the world." Romanelli has served as president of human health international for MSD, a global healthcare company that develops and manufactures medicines, vaccines, biologic therapies, and animal health products, since 2022. In this role, he oversees MSD's 75-plus markets outside of the US and leads a team of 14,000 colleagues. Prior to joining MSD, Romanelli served as the chief executive officer of JiXing Pharmaceuticals, a China-based biopharmaceutical company. Previously, he served in a variety of strategic and operational roles with increasing responsibility at MSD and Schering-Plough for 25 years.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
